Fishman P, Cohen S, Itzhak I, Amer J, Salhab A, Barer F, et al. The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice. Int J Mol Med. 2019;44:2256-2264 pubmed publisher

Yang D, Zhang Q, Ma Y, Che Z, Zhang W, Wu M, et al. Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the Akt/p21-dependent senescence to apoptosis. EBioMedicine. 2019;47:114-127 pubmed publisher

Cohen S, Barer F, Itzhak I, Silverman M, Fishman P. Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson. J Immunol Res. 2018;2018:2310970 pubmed publisher

Sowa N, Street S, Vihko P, Zylka M. Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-bisphosphate. J Neurosci. 2010;30:10282-93 pubmed publisher

Mitchell C, Peterson Yantorno K, Carre D, McGlinn A, Coca Prados M, Stone R, et al. A3 adenosine receptors regulate Cl- channels of nonpigmented ciliary epithelial cells. Am J Physiol. 1999;276:C659-66 pubmed publisher

Li A, Moro S, Melman N, Ji X, Jacobson K. Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem. 1998;41:3186-201 pubmed